Athens Medical C.S.A. (ATH:IATR)

Greece flag Greece · Delayed Price · Currency is EUR
1.905
-0.005 (-0.26%)
At close: Dec 5, 2025
23.70%
Market Cap 165.23M
Revenue (ttm) 270.92M
Net Income (ttm) -4.73M
Shares Out 86.74M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend 0.02 (1.05%)
Ex-Dividend Date n/a
Volume 1,906
Average Volume 8,316
Open 1.910
Previous Close 1.910
Day's Range 1.870 - 1.920
52-Week Range 1.475 - 2.350
Beta 0.90
RSI 53.74
Earnings Date Dec 30, 2025

About Athens Medical C.S.A.

Athens Medical C.S.A., together with its subsidiaries, offers healthcare services in Greece and internationally. The company offers diagnosis and treatment for prostate bladder, kidney, and testicular cancer, as well as interventional cardiology, interventional electrophysiology, and pediatric cardiology; cardiac surgery; robotic surgery, including general, gynecologic, and urology services; and neuro- and spine surgery services. It also provides medical services for range of orthopedics, such as foot and ankle, hand and wrist, hip, knee, shoul... [Read more]

Sector Healthcare
Founded 1983
Employees 3,495
Stock Exchange Athens Stock Exchange
Ticker Symbol IATR
Full Company Profile

Financial Performance

In 2024, Athens Medical C.S.A.'s revenue was 269.85 million, an increase of 4.44% compared to the previous year's 258.36 million. Earnings were 1.78 million, a decrease of -77.99%.

Financial Statements

News

There is no news available yet.